Moreover, TBMS II can reduce the redox related oxidative stress, inhibit the activation of epidermal growth factor receptor (EGFR) and inhibit TGF-β1-induced multiple transfer steps, thereby inhibiting the adhesion, migration of human retinoblastoma cells and invasion (Chen et al., 2021). The gene discussed is EGFR; the disease is retinoblastoma.